About AIkido Pharma
AIkido Pharma is a biotechnology development company focused on the healthcare sector. The company primarily develops a diverse portfolio of early and mid-stage small-molecule anti-cancer therapeutics, with a focus on treatments for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia (ALL). Additionally, AIkido Pharma holds an exclusive worldwide license to a broad spectrum antiviral drug platform, which includes potential treatments for multiple viruses. It was founded in 1967 and is based in New York, New York.
Expert Collections containing AIkido Pharma
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
AIkido Pharma is included in 1 Expert Collection, including Psychedelics.
Latest AIkido Pharma News
May 3, 2023
02/01/2021 EDT Message : *Required fields Convergent Therapeutics, Inc announced that it has entered into a convertible promissory note purchase agreement for gross proceeds of $2,000,000 with AIkido Pharma Inc. (NasdaqCM:AIKI) on February 1, 2021.
AIkido Pharma Frequently Asked Questions (FAQ)
When was AIkido Pharma founded?
AIkido Pharma was founded in 1967.
Where is AIkido Pharma's headquarters?
AIkido Pharma's headquarters is located at One Rockefeller Plaza, New York.